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The mammalian TET enzymes catalyze DNA demethylation. While they have been intensely 3 
studied as major epigenetic regulators, remarkably little is known about their physiological roles 4 
and extent of functional redundancy following embryo implantation. Here, we define non-5 
redundant roles for TET1 at an early post-implantation stage of the mouse embryo, when its 6 
paralogs TET2 and TET3 are not detectably expressed. TET1 regulates numerous genes 7 
defining differentiation programs in the epiblast and extra-embryonic ectoderm. In epiblast 8 
cells, TET1 demethylates gene promoters via hydroxymethylation and maintains telomere 9 
stability. Surprisingly, TET1 represses a majority of epiblast target genes independently of 10 
methylation changes, in part through regulation of a transcriptional repressor JMJD8. 11 
Dysregulated gene expression in the absence of TET1 causes embryonic defects, which are 12 
partially penetrant in an inbred strain but fully lethal in non-inbred mice. Collectively, our study 13 
reveals an interplay of catalytic and non-catalytic activities of TET1 essential for normal 14 
development.  15 
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Dynamic changes in cytosine methylation are critical components of genome-wide 16 
epigenetic events that program the early mammalian embryo for development1,2. DNA 17 
methylation of CpG dinucleotides at gene promoters often elicits transcriptional repression 18 
critical for cell fate commitment3,4. The role of DNA methylation erasure mechanisms during 19 
early peri/post-implantation stages is much less understood. 20 
Mouse embryonic stem cells (ESCs) derived from the inner cell mass (ICM) of 21 
embryonic day (E )3.5 blastocysts are in vitro models of “naive” pluripotency, a feature of full 22 
developmental potency5.  However, ESCs in conventional serum cultures deviate from native 23 
ICM by gaining de novo DNA methylation6-8. To reach a “ground-state” that recapitulates the 24 
ICM, ESCs are re-adapted to serum-free medium containing leukemia inhibitory factor (LIF) 25 
and inhibitors of MEK and GSK3 (2iL)6. ESCs in 2iL can be differentiated in vitro into 26 
“primed” epiblast-like cells (EpiLCs) that mimic the E5.5-6.0 pre-gastrulation epiblast9. In 27 
comparison, epiblast stem cells (EpiSCs) derived from post-implantation E5.5-7.5 epiblasts all 28 
progress in culture to resemble the E7.5 anterior primitive streak of the mouse gastrula10-12. An 29 
adequate choice of in vitro models is therefore crucial for capturing rapidly changing cellular 30 
states of peri-/post-implantation development. 31 
The Ten-Eleven-Translocation (TET) DNA dioxygenases (TET1, TET2 and TET3) 32 
erase DNA methylation by reiterative oxidation of 5-methylcytosine (5mC) to 5-33 
hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC)13-15. 34 
The contributions of TET1 and TET2 in naive pluripotency, where both are highly expressed, 35 
have been intensely studied in ESCs16-19.  Because Tet1 and Tet2 expression levels are low in 36 
EpiSCs, both genes were presumed to be silenced soon after implantation7,20. However, we 37 
recently showed a persistence of Tet1 expression and silencing of only Tet2 in the transition 38 
from ESCs to EpiLCs21.   39 
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The embryonic lethality of Tet1-deficient mice has been controversial22-25 40 
(Supplementary Note 1). On the basis of functional redundancies between TET enzymes, recent 41 
studies have examined embryonic defects in combined Tet double and triple KOs25-27. However, 42 
the precise roles of individual TET enzymes during development remain un-resolved. In this 43 
report, we demonstrate novel non-redundant functions of TET1 in pre-streak mouse embryos 44 
and EpiLCs. 45 
Results 46 
Tet1 is detected with genomic 5hmC in the primed epiblast 47 
To profile temporal and spatial expression of Tet1, Tet2 and Tet3 in mice at early post-48 
implantation stages, we performed whole-mount in situ hybridization (WISH) on C57BL/6 (B6) 49 
embryos. Tet1 expression was prominent in the epiblast at E6.5, but rapidly diminished at E7.5 50 
with faint persisting detection in the anterior half of the gastrula (Fig. 1a). During these stages, 51 
Tet2 and Tet3 were undetectable by WISH and quantitative PCR (Fig. 1a,b). At E8.5, Tet1 and 52 
Tet3 were weakly expressed in the head folds and neural tube, whereas Tet2 was not detectable. 53 
At E9.5-10.5, all three Tet genes were expressed in the developing brain (Fig.  1a,b).  54 
Given that the TET proteins catalyze the formation of 5hmC, we next analyzed genomic 55 
5hmC distribution in the early post-implantation embryo. Based on immunohistochemistry and 56 
dot blot detection, 5hmC was enriched in the E6.5 epiblast (Epi) compared to the extra-57 
embryonic ectoderm (ExE) and surrounding decidual tissues (Fig.  1c,d). The 5hmC patterns 58 
faded out at E7.5-8.5 and reappeared in tissue-specific regions at E9.5-10.5 (Fig.  1d, 59 
Supplementary Fig. 1a and data not shown), in line with the expression patterns of Tets. Thus, 60 
whereas all three TETs may collectively contribute 5hmC in the E9.5-10.5 embryo, TET1 61 
appears to have a unique role in the E6.5 epiblast.  62 
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Loss of TET1 causes early embryonic defects 63 
We asked whether the solitary expression of Tet1 in the E6.5-7.5 epiblast had any functional 64 
implication. In previous studies, Tet1 gene-targeted KOs were generated by deletions 65 
surrounding exon 11, which encodes the catalytic site; nonetheless, deletions of only 3’ exons 66 
may allow expression of a N-terminal fragment (~70 kDa). To delineate the implication of more 67 
complete loss of TET1, we first examined the Tet1 GT(RRG140) strain (donor 129P2/OlaHsd), 68 
which disrupted transcription after the first coding exon (exon 2) on the mutant allele 69 
(Supplementary Fig. 1b-h).  70 
X-Gal staining in heterozygous (het) Tet1GT/wt embryos recapitulated the developmental 71 
patterns of Tet1 expression as observed by WISH (Fig. 1e-f, Supplementary Fig. 2a,b and 72 
Supplementary Note 2). Interestingly, Tet1GT/GT embryos obtained from early mixed-strain 73 
inter-crosses (generations N≤3 backcrosses to B6) were developmentally abnormal compared 74 
to wild-type (wt) and het littermate embryos from E8.0 and none survived beyond E9.5 75 
(Supplementary Fig. 2c,d). Further backcrossing (N>5) produced viable Tet1-deficient mice, 76 
but these were born below the expected Mendelian ratio and developmentally stunted (Fig. 1g-77 
j, Supplementary Fig. 2e,f and Supplementary Note 1). These observations indicate embryonic 78 
defects at late gastrulation in both inbred and non-inbred Tet1-deficient strains in vivo; the 79 
degree of penetrance is surprisingly reduced by inbreeding. 80 
To validate these GT phenotypes by an independent strategy, we generated a B6 line 81 
containing a Tet1-targeted mutation (Tet1tm1Koh), in which the lacZ reporter is inserted in-frame 82 
immediately downstream of the ATG start codon (Supplementary Fig. 2g). This approach 83 
effectively ablates expression of the full coding sequence of Tet1. In this mutant, we again 84 
observed embryonic defects that recapitulated observations in the incipient congenic B6 85 
Tet1GT/GT mice. By E9.5, several Tet1-null embryos showed deformities in forebrain 86 
development associated with incomplete closure of the anterior neuropore (Fig. 1k). 87 
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Collectively, our analysis in two alternative Tet1-mutant strains may have revealed additional 88 
non-catalytic functions of TET1 requiring its N-terminal domain.  89 
Intriguingly, Tet1GT/GT embryos were more intensely stained by X-Gal and in broader 90 
regions compared to Tet1GT/wt littermates (Fig. 1f,g and Supplementary Fig. 2c-f). We reasoned 91 
that the presence of biallelic lacZ reporters in Tet1GT/GT embryos has revealed expression of the 92 
GT fusion product in somatic and extra-embryonic cells, otherwise below detection threshold 93 
when only a single allele is expressed in Tet1GT/wt embryos (Supplementary Note 3). If this 94 
premise were valid, we would expect Tet1lacZ/wt embryos from the Tet1tm1Koh strain, which 95 
expresses -galactosidase directly from the Tet1 promoter without gene fusion, to have a lower 96 
threshold for X-Gal detection and stain like Tet1GT/GT embryos. Indeed, E6.5 Tet1lacZ/wt embryos 97 
stained very intensely in the epiblast, with lighter staining also observed in the ExE 98 
(Supplementary Fig. 2h), indicating Tet1 expression at differential levels in both embryonic and 99 
extra-embryonic lineages.  100 
TET1 regulates lineage genes in the pre-streak mouse epiblast 101 
On the basis of its expression, we examined the impact of TET1 loss on gene expression in the 102 
pre-gastrula embryo. Incipient congenic (N=5-6) B6 embryos were collected from Tet1GT/wt 103 
(het) intercrosses at E6.25 - staged by visible absence of the primitive streak (PS), the first 104 
morphological hallmark of gastrulation - and dissected separately into Epi and ExE for RNA-105 
sequencing (RNA-seq) (Fig. 2a, Supplementary Note 4, Supplementary Fig. 3a-c).  106 
Among differentially expressed (DE) genes in the Tet1-deficient Epi were several 107 
lineage markers (Fig. 2b, Supplementary Fig. 3d and Supplementary Table 1, 2). Tet1 was not 108 
detected by these criteria because of reads mapped to exon 2 (1.9-kb) in Tet1GT/GT samples; 109 
otherwise, reads downstream of the GT were absent (Fig. 2c). Interestingly, heat map clustering 110 
of DE genes showed most to be up- rather than down-regulated in Tet1GT/GT Epi (Fig. 2d);  111 
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several were PS markers, which were lowly expressed in wt and het Epi as expected at the pre-112 
streak (6.25) stage. They included Twist1 and Cd44, both associated with epithelial-to-113 
mesenchymal transition28 – a trait of PS formation – and the mesodermal transcription factors 114 
Barx1 and Bin1 (Fig. 2e and Supplementary Fig. 3d). These Tet1GT/GT Epi profiles are 115 
suggestive of precocious entry into mesendodermal fate that precedes morphological 116 
manifestation of the PS, further evidence that TET1 regulates the onset of gastrulation. 117 
Notably, the few genes down-regulated in Tet1GT/GT Epi included Nnat (neuronatin, also 118 
known as Peg5) and Lefty2 (Fig. 2f). Nnat has been implicated in promoting neuronal fate in 119 
ESCs29. Lefty blocks TGFβ/Nodal signaling by graded spatial expression in the gastrulation-120 
stage embryo to regulate lineage segregation30. Together, loss of Nnat and Lefty2 expression in 121 
Tet1-deficient Epi is consistent with observations of hyperactive Nodal signals and skewing 122 
towards mesendoderm when Tet1-deficient ESCs differentiate into embryoid bodies in vitro16. 123 
In wt E7.5 embryos, Lefty2 was prominently detected in the embryonic mesoderm in the 124 
posterior lateral region by WISH (Fig. 2g). In Tet1GT/GT littermate embryos, Lefty2 was 125 
posteriorly restricted and reduced in expression, both in inbred and outbred mice (Fig. 2g), 126 
confirming Lefty2 as a gene regulated by TET1 in vivo.  127 
To examine whether loss of TET1 affected DNA methylation at DE genes identified in 128 
vivo, we performed locus-specific bisulfite sequencing (BS). Tet1GT/GT Epi exhibited increased 129 
methylation (5mC and 5hmC) within an intragenic CpG island (CGI) of Lefty2 (Fig. 2h and 130 
Supplementary Fig. 3e), consistent with TET1 occupancy over this locus as previously shown 131 
in ESCs18. Similarly, Tet1 CGI promoter and enhancer sites showed substantial increase in 132 
methylation in Tet1GT/GT cells (Fig. 2i and Supplementary Fig. 3f), in agreement with auto-133 
regulation by TET131. However, the Nnat promoter was fully methylated in wt and Tet1GT/GT 134 
Epi (data not shown). On the other hand, the Cd44 transcription start site (TSS) gained 135 
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methylation upon loss of TET1, although gene expression increased (Fig. 2j), suggesting that 136 
gain in promoter methylation upon loss of TET1 does not strictly repress gene expression.  137 
TET1 suppresses metabolic genes in the extraembryonic ectoderm 138 
Next, we examined TET1 loss-of-function in the ExE. Consistent with Tet1 expression, RNA-139 
seq produced reads mapping to Tet1 exons in wt ExE samples, albeit at lower levels than in the 140 
Epi (compare Fig. 2c and 3a). Reads were evidently reduced in het ExE samples, compatible 141 
with sub-threshold X-Gal detection of Tet1-reporter activity in het ExE (Supplementary Fig. 142 
3c). In contrast, few reads were found for Tet2 and Tet3 (< 2 RPKM), validated by quantitative 143 
PCR (Fig. 3b). These observations confirmed TET1 as the dominant TET also in the ExE, 144 
without significant compensation by TET2 and TET3 in its absence. 145 
Pairwise comparisons between Tet1GT/GT and either het or wt ExE identified 15 DE genes 146 
(false discovery rate or FDR < 0.05) (Fig. 3c, Supplementary Tables 2, 3). Heat map clustering 147 
clarified 12 of these to be up-regulated, and only 3 (including Tet1) down-regulated, in Tet1GT/GT 148 
samples (Fig. 3d). Although five genes appeared up-regulated in wt relative to het (FDR < 0.05), 149 
they were expressed at very low levels (RPKM values < 5) and likely reflected transcriptional 150 
noise. When additional DE genes using a less stringent cut-off (P < 0.001) were included, 151 
several were highly expressed metabolic genes (Atp5l, Pfdn4, Polr2k, Rpa3, Rpl22l1, Rps27l, 152 
Uqcrb) up-regulated by 1.5-2 fold in Tet1GT/GT ExE (Supplementary Fig. 4a,b). On the other 153 
hand, Dmkn, Efcc1, Xaf1were silent in wt and het but activated upon loss of TET1  (Fig. 3e and 154 
Supplementary Fig. 4b).  155 
When DE genes (P < 0.05) were subjected to Ingenuity pathway analysis (IPA), the top 156 
pathways were related to mitochondrial dysfunction and oxidative phosphorylation (Fig. 3f). 157 
Indeed, several components of the mitochondrial electron transport chain were up-regulated by 158 
1.5- to 2-fold in the Tet1GT/GT ExE (Supplementary Fig. 4c and Supplementary Table 4). 159 
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Although these fold-changes were moderate, the collective up-regulation of multiple pathway 160 
components may amplify into a biologically significant effect.  161 
A shift in metabolic dependence from glycolysis to oxidative respiration is a hallmark 162 
of epiblast differentiation32. The metabolic profiles of the ExE were until now unknown. To 163 
address whether the up-regulated DE profile of Tet1GT/GT ExE indicated an altered metabolic 164 
and differentiation status, we used trophoblast stem cell (TSC) lines derived from the E6.5 165 
ExE33. The epigenetic status of TSCs differ markedly from that of the ExE34, including low 166 
levels of expression of all Tets upon culture adaptation (Supplementary Fig. 4d); nonetheless, 167 
they are the closest available in vitro correlates of the ExE. We observed that DE genes 168 
upregulated in Tet1GT/GT ExE were also up-regulated during TSC differentiation by growth 169 
factor withdrawal (Fig. 3g). Moreover, differentiation was associated with increased 170 
mitochondrial respiratory capacity (Fig. 3h). Collectively, these results suggest that subsistence 171 
levels of Tet1 in the ExE regulate the balance between glycolytic and oxidative metabolic 172 
pathways, loss of which triggers a metabolic shift favoring precocious differentiation.  173 
We then examined the methylation status at the promoters of 13 DE genes by high-174 
throughput bisulfite sequencing. At four loci (Xaf1, Efcc1, Rpa3 and Pet100), loss of 175 
methylation was associated with gain of gene expression in Tet1GT/GT ExE (Fig. 3i,j, 176 
Supplementary Fig. 4e,f). A striking example was Xaf1, where promoter methylation was 177 
drastically reduced from 60.3% to 1.7% by loss of TET1. Interestingly, both Xaf1 and Efcc1 178 
were DE genes silent in wt but activated in Tet1GT/GT, suggesting that de-repression of genes in 179 
TET1–deficient ExE may involve erasure of methylation. Moreover, the Tet1 enhancer site also 180 
lost methylation in Tet1GT/GT ExE (Fig. 3k), whereas the same locus was 100% methylated in 181 
Tet1GT/GT Epi isolated from the same pool of embryos (Fig. 2i). On the other hand, loss of TET1 182 
increased gene expression levels of Aph1b and Uqcrb along with gain in promoter methylation, 183 
but had no effect on the remaining 6 loci (Supplementary Fig. 4g,h). The lack of detectable 184 
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5hmC in the ExE (Fig. 1d) implies that methylation counts can be largely attributed to 5mC. 185 
Thus, our results suggest a contribution of TET1 in basal 5mC maintenance at specific sites in 186 
the ExE, which invokes a mechanism of action opposite to that more prevalent in the Epi, i.e. 187 
to erase 5mC.  188 
TET1 regulates the DNA methylome in primed epiblast-like cells 189 
The highly detectable Tet1 and genomic 5hmC in the primed epiblast prompted us to examine 190 
further global TET1 loss-of-function effects on the transcriptome and methylome in the epiblast 191 
lineage. To facilitate these studies, we used EpiLCs in vitro by first deriving wt, het and 192 
Tet1GT/GT (hereafter referred to as KO; Supplementary Fig. 5a,b) ESC lines from individual 193 
blastocysts of incipient congenic (N5 or >95% B6) Tet1 GT intercrosses. All lines (in triplicates 194 
per genotype) efficiently differentiated to EpiLCs. As previously shown, the omission of 195 
Activin A did not affect naïve-to-primed conversion35. However, loss of TET led to a notable 196 
reduction in total 5hmC content in EpiLCs, as measured by dot blots and ELISA (Fig. 4a,b). 197 
These differences between KO and controls (wt and het) were less prominent when ESCs were 198 
maintained in serum and LIF (SL). The loss of 5hmC in KO EpiLCs had minor effects on global 199 
5mC content during naive-to-primed transition (Supplementary Fig. 5c,d). These observations 200 
suggest that loss of TET1 may affect the methylome landscape in primed pluripotent cells.  201 
To profile the methylome of EpiLC lines, we first performed 5hmC and 5mC methylated 202 
DNA immunoprecipitation (respectively hMeDIP and MeDIP) (Supplementary Note 5). By this 203 
approach, we identified 11,659 regions with differential 5hmC signals in KO compared to wt 204 
(or het), of which 71% exhibited loss in KO, as well as 976 regions with enriched 5mC signals 205 
in KO, of which 32% resided within CGI regions (Supplementary Fig. 5e-i). Importantly, these 206 
changes in Tet1 KO EpiLCs were largely not inherited from pre-existing differences between 207 
KO and wt ESCs cultured in 2iL (Supplementary Fig. 5j-l), suggesting that TET1 continues to 208 
regulate the DNA methylome after transition to primed pluripotency. 209 
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Therefore, we performed whole genome bisulfite sequencing (WGBS) in parallel 210 
bisulfite (BS) and oxidative bisulfite (oxBS)36 converted libraries to obtain base-resolution 211 
profiles of 5mC and 5hmC in wt and KO EpiLCs (2 independent lines each) (Supplementary 212 
Fig. 6a and Supplementary Note 6). More than 80% of methylated Cs (mCs) were found at 213 
CpGs (Supplementary Fig. 6b). In KOs, methylated CpGs appeared to be re-distributed from 214 
50-100% highly methylated to lowly methylated regions of 10-50%; the latter are known to be 215 
enriched for CpG poor distal regulatory regions37 (Fig. 4c and Supplementary Fig. 6c,d). 216 
Although recent studies have shown a globally hypomethylated genome in female 217 
compared to male ESCs8,20, these differences are less pronounced in EpiLCs38.  Because two of 218 
our KO lines were females while all control lines were male, our dot blot, MS and MeDIP 219 
analyses likely underestimated gains of methylation in KOs. Supporting this deduction, we 220 
identified several differentially methylated regions (DMRs), >90% with elevated DNA 221 
methylation levels, in the male KO line (#12) compared to a male wt line (#15) (Fig. 4d, 222 
Supplementary Table 5 and Supplementary Data files 1-4). DMRs spanned 1-2 kb and 223 
overlapped predominantly gene body (exons and introns) and promoter regions (Fig. 4e). Even 224 
in female KO EpiLCs, 5mCpG levels were marginally elevated at CGIs despite global loss at 225 
other genomic regions (Supplementary Fig. 6e), consistent with our MeDIP results. Therefore, 226 
TET1 regulates 5mC patterns at specific genomic features in EpiLCs, in conformity with its 227 
DNA demethylating function. 228 
We then identified 5hmC in EpiLCs and estimated that 80-90% resided within CpGs 229 
(Supplementary Fig. 6f), in agreement with previous base-resolution 5hmC profiling in ESCs39. 230 
An average of 502,874 CpGs in wt and 384,633 in KO EpiLCs were identified to contain 5hmC; 231 
the majority exhibited 5hmC levels of 20-60% occupancy and coincided with fully methylated 232 
(90-100%) sites profiled by BS (Supplementary Fig. 6g,h).  At a global scale, these 5hmC levels 233 
may constitute only ~0.04% of all Cs, barely above the detection limit of mass spectrometry, 234 
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but nonetheless can be biologically critical when localized at regulatory sites. When global 235 
5hmC levels were distributed by annotated genomic features, depressed levels were discernible 236 
in KO EpiLCs at CGIs (Supplementary Fig. 6i).  237 
To determine whether differentially hydroxymethylated CpGs in KO EpiLCs were 238 
concentrated at TET1-bound regions, we performed TET1 antibody chromatin 239 
immunoprecipitation-sequencing (ChIP-seq). Interestingly, we observed a concentration of 240 
TET1 occupancy sites within promoter regions in EpiLCs, to a greater extent than previously 241 
determined in serum-cultured mouse ESCs18 (Fig. 4f). Globally, TET1-bound regions are 242 
centered at unmethylated sites, in line with demethylating activity (Fig. 4g and Supplementary 243 
Fig. 6j). These regions exhibited elevated 5mC and reduced 5hmC levels in KO, where 5mC-244 
to-5hmC conversion at peak centers were evident in wt but absent in KO (Fig. 4h-j). 245 
Collectively, our results strongly suggest that TET1 regulates DNA methylation via 246 
hydroxymethylation at gene proximal promoters in the primed epiblast.  247 
Loss of TET1 affects gene expression independently of methylation changes 248 
We next asked how the impact of TET1 on the EpiLC methylome influences gene expression. 249 
By RNA-seq, we identified 613 DE genes (FDR < 0.05) in KO versus wt (DE1), 133 in KO 250 
versus het (DE2) and only three in the het versus wt (DE3) pairwise comparisons (Fig. 5a, 251 
Supplementary Tables 6, 7, Supplementary Note 7). When the 613 genes in DE1 were 252 
overlapped with TET1-bound regions defined by ChIP-seq, we observed ~40% to be bound by 253 
TET1 (Fig. 5b). The majority (~72%; 441 genes) gained expression in Tet1 KO EpiLCs (Fig. 254 
5c). Gene ontology (GO) analysis of DE1 up-regulated genes revealed MHC class I protein 255 
complex and structural molecule activity as the only significantly enriched terms; of down-256 
regulated genes, the only term was nucleic acid binding (Supplementary Fig. 7a). Over 60% of 257 
DE genes were not associated with oxWGBS-defined DMRs (Fig. 5c).  258 
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In contrast, GO and KEGG enrichment analyses of WGBS DMRs showed highly 259 
significant enrichment of terms for diverse biological processes and diseases (Supplementary 260 
Fig. 7b,c), in stark contrast to the limited GO terms from differential gene expression analysis. 261 
These results provocatively suggest that while loss of TET1 impacted the DNA methylome in 262 
EpiLCs, these effects do not yet affect expression of over 90% of associated genes (Fig. 5c).  263 
TET1 regulates telomere stability in primed epiblast-like cells 264 
We focused on 95 DE genes commonly dysregulated in KO versus wt or het. Almost 265 
70% of these gained expression in Tet1 KO EpiLCs (Fig. 5a,d and Supplementary Tables 6, 7). 266 
The smaller set of DE genes down-regulated by Tet1 KO included the entire Zscan4a-f cluster. 267 
Zscan4 is known to be critical for telomere maintenance, as a means to maintain karyotype 268 
integrity in ESCs40,41. Because Zscan4 was previously shown to be up-regulated in Tet triple 269 
KO serum-cultured ESCs42, we measured Zscan4c/d/f expression in cells cultured in serum and 270 
LIF (SL), 2iL and EpiLC conditions to reconcile this discrepancy. We observed that Zscan4 271 
expression indeed increased in KO SL ESCs, but decreased in 2iL and in EpiLCs 272 
(Supplementary Fig. 8a), suggesting that this gene cluster can be dynamically regulated by 273 
TET1 in different cell states.  274 
To demonstrate a defect in telomere homeostasis in Tet1 KO cells, we performed flow 275 
cytometry-fluorescence in situ hybridization (flow-FISH), which uses a fluorescent probe to 276 
measure telomere lengths in cells at G1 phase of the cell cycle. This method revealed a 277 
significant increase in cells harboring shortened telomeres in all three KO lines upon conversion 278 
to EpiLCs (Fig. 5e,f). The defect was specific to primed-state cells, because naive KO ESCs in 279 
2iL showed no detectable fraction with shortened telomeres (Supplementary Fig. 8b). We note 280 
that others have recently shown a role for TET enzymes in regulating telomere length, but these 281 
effects were only noticeable in TET double- or triple KO ESCs42,43. Together, these results 282 
suggest that fluctuations in Zscan4 levels caused by loss of TET1 in naive pluripotent states 283 
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may have no measurable impact on telomere stability, but can be deleterious in primed 284 
pluripotency.  285 
To detect the presence of 5hmC at Zscan4, we performed amplicon-sequencing 286 
following TET-assisted BS (TAB)39 (Supplementary Note 8). At a unique TET1-bound site 287 
downstream of Zscan4f, we identified CpG sites containing 5hmC at levels of 10-30% in wt, 288 
which were significantly reduced in KO EpiLCs (Fig. 5g). Together, these results provide 289 
evidence for TET1 catalytic activity at the Zscan4 locus, together with a role in telomere 290 
maintenance, during transition to primed pluripotency.  291 
TET1 exerts catalytic-independent repression of target genes in the primed epiblast 292 
While TET1 is expected to promote DNA demethylation, we were surprised that the majority 293 
of DE genes were up-regulated in the KO Epi, EpiLCs and ExE. This may imply a gene 294 
regulatory mode of TET1 independent of 5mC oxidation, in line with a previous study 295 
suggesting gene regulation by TET1 even in methylation-deficient ESCs18. We therefore 296 
focused on the most biologically relevant DE genes identified in vivo, which can be further 297 
analysed in vitro using EpiLCs, by overlapping the DE datasets of EpiLC and Epi.  298 
Of the 10 genes in this shortlist, 8 were up-regulated, including Bin1, Cd44, Tnfrsfla and 299 
2 Ras family oncogenes (Fig. 6a). TET1 ChIP-qPCR validated that they were TET1-bound in 300 
EpiLCs (Fig. 6b and Supplementary Fig. 9a). Methylation changes at CpG sites flanking the 301 
promoters of these genes suggest that TET1 is indeed exerting DNA demethylating activity at 302 
its targets (Supplementary Fig. 9a). To resolve the paradox why loss of TET1 would increase 303 
gene expression despite gain of 5mC at promoters, we performed TET1 rescue in a KO line to 304 
demonstrate whether its repressive function involves 5mC oxidation. Re-expression of TET1, 305 
either as a full-length wt transcript or a catalytic dead mutant (Supplementary Fig. 9b-d), 306 
potently abrogated up-regulation of Bin1, Tnfrsfla, Rab20, Ppp1r1a, Kirrel and Rasl10b (Fig. 307 
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6c) in Tet1 KO EpiLCs. These results are strongly suggestive of TET1 catalytic-independent 308 
activity that represses target genes in the primed epiblast. 309 
Strain-specific modifiers of Tet1 KO phenotype 310 
To determine why mixed strain and outbred  Tet1 KO showed full embryonic lethality compared 311 
to partial lethality in B6 KO (Supplementary Note 1), we examined wt and KO CD-1 EpiLCs 312 
converted from ESC lines (two males and one female per group), derived from Tet1 GT mice 313 
after 3 generations of out-breeding. In the genetically heterogeneous background, RNA-seq 314 
identified 48 DE genes (FDR < 0.05). Heat map cluster showed again that the majority (~75%) 315 
were up-regulated, independently of gender differences (Supplementary Fig. 10a). Bin1, Cd44, 316 
Kirrel and Tnfrsf1a were DE genes common in CD1 and B6 KOs (Supplementary Fig. 10b), 317 
which showed enhanced differential expression in CD-1 relative to B6 (Fig. 6d). Moreover, GO 318 
analysis of DE genes in CD-1 KO revealed several terms (FDR < 10-4) related to regulation of 319 
cell differentiation and development, none of which were enriched in the analysis of B6 lines 320 
(Supplementary Fig. 10c). Together, these results provide molecular evidence that loss of TET1 321 
affected genes involved in differentiation more potently in non-inbred compared to inbred mice 322 
(Supplementary Note 9).  323 
Jmjd8 is a TET1 target gene that encodes a transcriptional co-repressor 324 
Interestingly, the two genes down-regulated both in B6 Tet1 KO Epi and EpiLCs included Tet1 325 
itself and Jmjd8, a relatively unknown Jumonji-family member (Fig. 6a). We showed two TSS-326 
proximal sites in Jmjd8 to be TET1-bound in EpiLCs (Fig. 6b). Expression of Jmjd8 in Tet1GT/GT 327 
Epi was diminished to basal levels compared to wt and het (Fig. 7a). In addition, Jmjd8 down-328 
regulation in vivo was associated with significant gains of methylation at two sites upstream of 329 
the TSS (Fig. 7b). These results strongly implicate Jmjd8 as a direct target of TET1 activity in 330 
the epiblast, prompting us to investigate its biological function further.  331 
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Jmjd8 belongs to the family of iron- and 2-oxoglutarate-dependent chromatin-332 
modifying enzymes that include TET DNA oxygenases and histone lysine demethylases. 333 
However, like the founder Jumonji member, JARID2, the JmjC domain of JMJD8 contains 334 
catalysis-mutating substitutions44. Supporting the possibility that JMJD8 may instead be a 335 
transcriptional repressor like JARID245, we observed that JMJD8 repressed both the 336 
mammalian thymidine kinase and viral SV40 promoters in dual reporter assays (data not 337 
shown). This repressive activity was validated either by using a promoter-less reporter to 338 
normalize for transfection (Fig. 7c), or by sorting transfected cells (Fig. 7d). Surprisingly, 339 
immunofluorescence detection of exogenous tagged protein showed full-length JMJD8 to be 340 
expressed predominantly in the cytosol (Fig. 7e). However, removal of a predicted N-terminal 341 
signal peptide (Fig. 7f) allowed expression of a truncated isoform (N-JMJD8) in both cytosol 342 
and nuclei (Fig. 7e and Supplementary Fig. 11a).  343 
To assess whether N-JMJD8 can bind target genes, we performed ChIP-seq of wt 344 
EpiLCs overexpressing tandem-tagged N-JMJD8 (Supplementary Fig. 11b). This analysis 345 
revealed co-localization of nuclear JMJD8 at TET1-bound sites (Fig. 7g,h and Supplementary 346 
Fig. 11c). The binding to the Bin1 and Tnfrsfla loci are likely to be functionally relevant, as 347 
these two genes were downregulated in KO EpiLCs upon over-expression of N-JMJD8 (Fig. 348 
7i and Supplementary Fig. 11d). Thus, the repressive effects of N-JMJD8 override the 349 
demethylating activity of TET1 at these genes, providing a functional link between catalytic 350 
and non-catalytic activities of TET1.  351 
Discussion 352 
Here, we demonstrate non-redundant functions of Tet1 at an early post-implantation stage and 353 
explain why previous Tet1-mutant mice, which ablated TET1 catalytic function, had little or no 354 
defects in utero24,25,46. In two alternative Tet1 null strains that ablate also the 5’ coding sequence, 355 
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we observed severe post-gastrulation defects, suggesting that while the catalytic domain of 356 
TET1 can be dispensable, further regulation by its N-terminus is critical for gastrulation. In 357 
agreement, TET1 represses several target genes in the epiblast without requiring its catalytic 358 
activity. Others have shown that TET1 interacts with Sin3A/HDAC18 or Polycomb repressors 359 
in ESCs31. Here, we identify JMJD8 as a new TET1 co-repressor.  360 
Surprisingly, few TET1-bound genes rely on DNA demethylation for expression.  We 361 
identified two of these as Jmjd8 and Lefty2; both coincidentally encode repressors of biological 362 
processes, in anti-thesis to the expected role for DNA demethylation to activate gene expression 363 
programs. Rather, our results implicate a role for TET1 as a safeguard against precocious 364 
differentiation of embryos at pre-gastrulation. Modest dysregulation of genes (Bin1, Cd44 and 365 
Kirrel) driving progression of differentiation may be tolerated in inbred embryos but more 366 
pronounced dysregulation becomes deleterious in non-inbred ones, accounting for the strain-367 
dependence of KO phenotypes.  368 
The maintenance of DNA methylation is essential for the viability of primed-state 369 
pluripotent cells, but dispensable in naive cells47. We found TET1 to be critical for preventing 370 
telomere shortening in EpiLCs by regulating Zscan4, raising the possibility that telomere 371 
maintenance requires regulation of DNA methylation in primed pluripotency. This impact on 372 
genome stability may be pertinent to a wide spectrum of diseases24,46,48 (Supplementary Note 373 
10). In conclusion, our study reveals critical roles for TET1 in non-catalytic gene regulation 374 
during primed pluripotency, whereas its catalytic effects on the DNA methylome may serve 375 
independently as an epigenetic safeguard against dysregulation later in post-natal development. 376 
The involvement of TET1 in the extra-embryonic methylome opens new avenues to understand 377 
the epigenetic regulation of placental development.  378 
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MAIN FIGURES LEGENDS 522 
Fig. 1. Tet1 expression and loss-of-function in the post-implantation mouse embryo. (a) 523 
WISH analysis of E6.5-10.5 C57BL/6 (B6) wild-type (wt) embryos. Proximal (Pr), distal (D), 524 
anterior (A) and posterior (P) axes refer to E6.5-8.5. (b) Quantitative RT-PCR of Tet transcript 525 
copies of Tet normalized to Gapdh. Error bars show SEM of biological replicates of ESC lines 526 
(n=3), pooled E6.0-7.0 epiblasts (n=3) and entire E8.5-10.5 embryos (n=5 or 6). Values for Tet1 527 
are obtained from Sohni. et al.21 (c) 5hmC immunostaining of serial E6.5 embryo sections. (d) 528 
5hmC dot blots of E6.5 Epi and ExE (left) and whole embryos (right). (e) Sagittal sections of 529 
X-Gal stained Tet1GT/wt embryos. (f-g) Transverse section of E7.5 Tet1GT/wt (f) and Tet1GT/GT (g) 530 
X-Gal stained embryos. Whole embryos with plane of section are indicated on the left. (h,i) 531 
Representative litters of E9.5 embryos from inter-crosses of Tet1GT/wt mice (h) and numbers of 532 
mice born at late backcross generations to B6 (N≥6). (j) A 4-week-old Tet1GT/GT mouse next to 533 
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a Tet1GT/wt littermate. (k) Representative litters of E9.5 embryos from inter-crosses of B6 534 
Tet1tm1koh heterozygous mice. Colored dotted lines delimit the same embryos shown in frontal 535 
or dorsal view on the right, and lateral on the left. Scale bars are 100 µm. Epi, epiblast; ExE, 536 
extra-embryonic ectoderm; HF, head folds; NT, neural tube; Ch, chorion; Am, amnion; Al, 537 
allantois; NE, neuroepithelium; EM, embryonic mesoderm; PS, primitive streak; VE, visceral 538 
endoderm. 539 
Fig. 2. Genes regulated by TET1 in the epiblast. (a) Embryo dissection procedure for RNA-540 
seq. (b) Venn diagram showing differentially expressed (DE) genes. Gene names highlighted 541 
in red are common to DE1 and DE2 using P < 0.001 (see Supplementary Fig. 3d). (c) 542 
Representative read coverage over Tet1. Positions of exons (E; E1a, E1b are alternative exons 543 
1) and GT insertion are indicated by black arrowheads. Y-axis indicates reads per million. (d) 544 
Heat map cluster of the DE genes shown in B. (e, f) Reads per kilobase million (RPKM) of 545 
selected up-regulated (e) and down-regulated (f) genes in the epiblast. (g) WISH detection of 546 
Lefty2 in E7.5 embryos from B6 and outbred CD1mice. (h-j) Bisulfite amplicon-sequencing 547 
analysis at Lefty2 (h), Tet1 (i) and Cd44 (j) in E6.25 Epi. Percentages in legends indicate average 548 
methylation levels of all CpGs over each loci. Data shown in (h) and (i) are representative of 549 
two independent biological replicate pools. Above, ChIP-seq tracks of TET1 occupancy in 550 
mouse ESCs18. Middle, relative CpG positions in the amplicon, delineated relative to 551 
transcription start sites. Paired Student’s t test, * P < 0.05. 552 
Fig. 3. Genes regulated by TET1 in the extraembryonic ectoderm. (a) Read coverage over 553 
Tet1, as described in Fig. 2c. (b) Tet expression, as described in Fig. 1b. Error bars show SEM 554 
of biological replicates (n=3 or 4). Dotted line indicates background detection. (c) Venn 555 
diagram of DE genes. Gene names highlighted in red are common to DE1 and DE2 using P < 556 
0.001 (see Supplementary Fig. 3a). (d) Heat map clustering of all DE genes shown in c. (e) 557 
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RPKM values of selected DE genes. ANOVA, * P < 0.05, ** P < 0.01, *** P < 0.001. (f) Top 558 
5 pathways identified by Ingenuity using P < 0.05. (g) Fold change in expression of DE genes 559 
in trophoblast stem cells (TSCs) cultured in the presence or absence of fibroblast growth factor 560 
4 (FGF4). Error bars show SEM of biological replicates (n=3 or 4 cell cultures). Unpaired 561 
Student’s t test, * P <0.05. (h) Oxygen consumption rate measured normalized to protein in 562 
TSCs. Error bars indicate SD of technical replicates (n=3). Inset shows a significant increase in 563 
normalized maximal respiration rates during differentiation. (i-k) Bisulfite amplicon-564 
sequencing analysis at Xaf1 (i), Efcc1 (j), and Tet1 (k) in E6.25 ExE, as described in Figures 565 
2h-j. Data shown here are representative of two independent biological replicate pools. 566 
Fig. 4. Effects of TET1 on the DNA methylome in epiblast-like cells. (a) Representative 567 
5hmC dot blots (left) and quantification (right). Serial dilution of an oligonucleotide containing 568 
5hmC (+) or lacking 5hmC (-) serve as standards (Std). Error bars indicate SEM of biological 569 
replicates (n=3 cell lines). (b) ELISA based 5hmC quantification of data from biological 570 
triplicate lines analyzed in 2-3 independent assays. Dotted horizontal line represent background 571 
level. Nested ANOVA, * P < 0.05, ** P < 0.01, *** P < 0.001. (c) Distribution of methylated 572 
CpGs (mCpG) (coverage ≥10) among unmethylated (< 10% where 0% is not included), lowly 573 
methylated (10-50%) and highly methylated fractions (50-100%). (d) Methylation levels of 574 
differentially methylated regions (DMRs) in a male wt (#15) and male KO (#12) EpiLC line. 575 
(e) Distribution of DMRs identified by WGBS and oxWGBS among genomic features. (f) 576 
Distribution of TET1 ChIP-seq peak regions classified by genomic features in EpiLCs (2 577 
replicate lines) and in a published ESC dataset18. (g) Heat map showing 5mC levels (mean of 578 
replicate oxWGBS profiles) within 100bp bins spanning ±5kb regions centred at TET1 ChIP-579 
seq peaks. Heat maps for individual samples are shown in Supplementary Fig. 6j. (h, i) Average 580 
5mC (h) and 5hmC (i) levels at TET1 binding peaks (summit peak ±200bp). Dotted horizontal 581 
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line represent the median level of wt samples. (j) Line plot of average hmC over mC levels at 582 
±5kb regions centered at TET1 ChIP-seq peaks.  583 
Fig. 5. Genes regulated by TET1 in epiblast-like cells. (a) Venn diagram showing DE genes 584 
at FDR < 0.05. (b) Overlap of DE1 genes (KO vs wt) with genes associated with TET1 binding. 585 
(c) Overlap of up- and down-regulated genes in DE1 with DMRs from oxWGBS analysis shown 586 
in Fig. 4i. (d) Heat map cluster of 95 DE genes in the overlap of DE1 and DE2 shown in 5a. (e-587 
f) Flow-FISH analysis of B6-EpiLC lines. Each line was analyzed in technical duplicates 588 
(shown as light and dark blue line profiles), with percentage values of fractions shown as mean 589 
± SD in e. The values of sub-telomere length fractions are shown as mean ± SEM from the 590 
biological triplicates in f. (g) Bisulfite (BS) and TET-assisted bisulfite (TAB) amplicon-591 
sequencing analysis at a Zscan4f locus. Error bars are SEM of biological triplicate EpiLC lines. 592 
Above, ChIP-seq tracks of TET1 occupancy in mouse ESCs18.  Paired Student’s t test, * P < 593 
0.05.   594 
Fig. 6. Target genes of TET1 in the epiblast. (a) Venn diagram overlap of TET1-regulated 595 
DE genes common in Epi and EpiLCs. (b) TET1 ChIP-qPCR at DE genes in EpiLCs. Error 596 
bars indicate SEM of biological triplicate lines. (c) Repression of DE genes upon rescue 597 
overexpression of full length TET1 wt and catalytic mutant (mut HxD) transcripts in Tet1 KO 598 
EpiLCs. Error bars indicate SEM of 2 (wt+empty vector), 3 (KO+empty and KO+TET1) and 4 599 
(KO+TET1 mut HxD) transfected clones; expression levels are relative to one mock-transfected 600 
KO clone. (d) Expression of DE genes in B6 versus CD-1 wt and KO EpiLCs. Error bars 601 
indicate SEM of biological triplicate lines; expression is relative to one CD1 wt EpiLC line. 602 
ANOVA, * P < 0.05, ** P < 0.01, *** P < 0.001. 603 
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Fig. 7. Transcriptional repression by JMJD8. (a) RPKM of Jmjd8 in the Epi (b) Bisulfite 604 
amplicon-sequencing analysis in E6.25 Epi. Above, TET1 ChIP-seq peaks in wt EpiLC. Paired 605 
Student’s t test, * P < 0.05. (c) Dual reporter luciferase assay in HEK293T cells indicating 606 
thymidine kinase promoter-driven Renilla activity (normalized to co-transfected promoter-less 607 
pGL3-basic) upon over-expression of JMJD8, a truncated JMJD8 nuclear isoform (N-JMJD8) 608 
or empty vector. Error bars indicate SEM of 3 independent experiments. (d) Single reporter 609 
luciferase assay in HEK293T cells normalized to protein content in cells sorted for transfection. 610 
Error bars indicate SEM of 3 independent experiments. ANOVA, * P <0.05, ** P < 0.01, *** 611 
P < 0.001. (e) Confocal images of HEK293T expressing full length or truncated C-terminal 612 
tagged JMJD8 stained with an anti-6xHis antibody. White arrows indicate two cells showing 613 
nuclear staining.Scale bars are 50 m. (f) Schematic representation of JMJD8 indicating the 614 
predicted signal peptide (SP) and JmjdC domain. The SP-deleted isoform is N-JMJD8. (g) 615 
Heat map depiction of 1295 N-JMJD8-His ChIP peaks (>4 RPKM at the summit peak ± 200 616 
alongside N-JMJD8-V5 and TET1 ChIP peak intensities. (h) TET1 and JMJD8 ChIP-seq 617 
peaks and mCpG levels at Bin1 and Tnfr1s1a in EpiLCs. Regions showing co-binding of TET1 618 
and JMJD8 are boxed. Statistically validated 5hmCpGs in wt EpiLC are highlighted in blue. (i) 619 
Expression of Bin1 and Tnfrsf1a in Tet1 KO EpiLCs expressing doxycycline (DOX)-inducible 620 
N-JMJD8, relative to wt. Error bars indicate SEM of 4 clonal transfected lines. Unpaired 621 
Student’s t test, * P <0.05.  622 
  623 
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Online Methods  624 
Characterization of Tet1 gene trap (GT). The Tet1GT/wt mouse line was generated by 625 
blastocyst injection of the gene trap ESC clone RRG140 (BayGenomics). Southern blot analysis 626 
was performed as previously described49. To map the GT insertion precisely, genomic DNA 627 
was sequenced by targeted locus amplification (Cergentis) as previously described50. SYBR 628 
Green-based quantitative measurement of LacZ gene copies was normalized to that of Ngf and 629 
calibrated to a targeted cell line harboring one allelic copy of LacZ 630 
(http://www.genetrap.org/info/protocols/baygenomics/QPCR_neo_Gene_dosage.pdf).   631 
 632 
C57BL/6-Tet1tm1Koh mouse creation.  Vector design, construction, gene targeting in C57BL/6 633 
ESCs, blastocyst injection and breeding of chimera to C57BL/6 using goGermline technology51 634 
were performed at Ozgene Pte Ltd (Australia). In this mouse model, a lacZ reporter is 635 
introduced immediately after the ATG start codon, flanked by 2 LoxP sites in a cassette that 636 
allows reporter exchange by Cre recombination (Supplementary Fig. 2g). 637 
 638 
Isolation of embryos. To collect pre-implantation embryos, 4- to 5-week old wild type female 639 
mice were super-ovulated by intraperitoneal injection of 5 IU pregnant mare serum 640 
gonadotropin (Sigma) followed by 7.5 IU human chorionic gonadotropin (Sigma) 46-48 h later, 641 
and then mated with Tet1GT/wt males. Embryos were collected at daily intervals at 1.5 days (8-642 
cell stage), 2.5 days (morula stage) and 3.5 days (blastocyst stage) post-coitum by flushing the 643 
oviduct (for 8-cells and morula) or the uterus (for blastocysts). Post-implantation embryos from 644 
E5.5 to E10.5 were isolated from naturally mated timed-pregnant mice. Upon isolation of intact 645 
post-implantation conceptuses from decidua, the outer Reichert’s membranes with attached 646 
parietal endoderm and trophoblast giant cells were removed with the aid of fine tungsten 647 
needles. To prepare E6.25 epiblast (Epi) and extra-embryonic (ExE) tissues for RNA-seq or 648 
bisulfite sequencing, embryos free of the Reichert’s membrane were incubated for 5-10 minutes 649 
at 4°C in 2.5% pancreatin/0.5% trypsin in Ca2+/Mg2+ free Tyrode Ringer’s saline solution, then 650 
washed in phosphate buffered saline (PBS). Epiblast and extra-embryonic tissues were 651 
subsequently separated; interface tissues were removed to minimize cross-contaminating cell 652 
types. To genotype embryos, cells of the ectoplacental cone, visceral endoderm layers or yolk 653 
sac cells were lysed at 55°C overnight in lysis buffer (10 mM Tris-HCl pH 8.3, 50 mM KCl, 2 654 
mM MgCl2, 0.45% NP40 and 0.45% Tween 20) supplemented with 1 µg/ml Proteinase K. 655 
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Digestion was stopped by 10 min incubation at 98°C anprior to PCR. Primers used for 656 
genotyping are listed in Supplementary Table 8. All experimental procedures on mice have been 657 
reviewed and approved by the KU Leuven Ethical Committee for Animal Experimentation 658 
(P177/2011) in compliance with the European Directive 2010/63/EU.  659 
 660 
Whole-mount in situ hybridization (WISH). Embryos were fixed overnight at 4°C in 4% 661 
paraformaldehyde (PFA) in PBS, dehydrated in increasing methanol concentrations in PBST 662 
(PBS+0.1% Tween 20) and stored in 100% methanol at -20°C until further processing, 663 
according to a standard on-line protocol with minor modifications during the staining steps 664 
(http://goodrich.med.harvard.edu/uploads/3/7/7/1/37718659/whole_mount_in_situ.pdf). 665 
Briefly, to detect the hybridized signal, embryos were washed with MABT (100 mM Maleic 666 
acid, 150 mM NaCl, pH 7.5 containing 0.1% Tween 20), pre-blocked in 20% serum, 2% 667 
Boehringer Blocking Reagent (Roche) at RT for 90-120 min, and then incubated overnight at 668 
4°C with 1/2000 dilution of an alkaline phosphatase (AP)-conjugated anti-dioxigenin antibody 669 
(Roche #11093274910) in blocking solution. After several washes in MABT of 1 hour each, an 670 
additional overnight wash at 4°C was performed. To limit the background signal and internal 671 
phosphatase activity of E9.5-10.5, embryos were washed three times for 15 min each with 2 672 
mM Levamisole (Sigma) in MABT. Detection of staining was performed using the BM purple 673 
AP-substrate (Roche #11442074001) for 6h-24h depending on the probe. The embryos were 674 
post-fixed with 4% PFA overnight at 4°C and stored in 70% ethanol (EtOH). Imaging was 675 
performed using a S8 APO stereomicroscope (Leica).  676 
Sense (negative control) and antisense RNA probes for Tet1, Tet2 and Tet3 were 677 
generated by PCR using primers flanked with SP6 or T7 sequences. Digoxigenin (DIG) labeling 678 
was performed using DIG RNA Labeling kit and T3 RNA polymerase (Roche). Primer 679 
sequences are listed in Supplementary Table 8. The Lefty2 probe was kindly offered by the lab 680 
of Dr Hamada52. More than 5 embryos from at least three different litters were stained per 681 
embryonic stage, per genotype (wt or TetGt/Gt) and per probe. 682 
 683 
X-Gal staining. Pre-implantation embryos and whole-mount E5.5-10.5 embryos were fixed in 684 
0.2% glutaraldehyde (Sigma), 2 mM MgCl2, 5 mM EGTA and 0.02% NP-40 in PBS at RT for 685 
15 -30 min (http://www.sanger.ac.uk/genetrap/). Fixation was followed by three washes in 2 686 
mM MgCl2, 0.02% NP-40 and 0.01% sodium deoxycholate in PBS. Staining for β-galactosidase 687 
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was performed in 1 mg/ml X-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) 688 
(Fermentas), 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 2 mM MgCl2, 0.02% 689 
NP-40 and 0.01% sodium deoxycholate in PBS at 37°C for 6h (pre-implantation Tet1 GT 690 
embryos and E6.5 Tet1LacZ/wt) or overnight (Tet1 GT post-implantation embryos). Post-691 
implantation embryos were post-fixed in 4% PFA overnight at 4°C, and stored in 70% EtOH at 692 
4°C until further use in paraffin sectioning. Pre-implantation embryos were pictured using a 693 
CKX41 Olympus microscope. For optimal whole-mount images, post-implantation embryos 694 
were further cleared in increasing concentrations of glycerol (25% to 100%) and imaged using 695 
a S8 APO stereomicroscope (Leica). For each embryonic stage, at least 6 embryos from more 696 
than four different litters were analyzed.   697 
 698 
Paraffin embedding and sectioning. X-Gal stained embryos were positioned properly in 1.5% 699 
agarose equilibrated at 60°C using Dumont #5 forceps (Roboz Surgical Instruments). The 700 
embryos were then further dehydrated and embedded in paraffin using an automated Excelsior 701 
ES system (Thermo Scientific). 5-µm thick sections were cut using a Microm HM360 702 
microtome and mounted and counter-stained with Mayer’s Hematoxylin and Eosin using 703 
standard protocols Stained sections were imaged using an upright CTR5500B microscope 704 
(Leica). 705 
 706 
5hmC immunohistochemistry. E6.5-E7.5 (within intact decidua) and E8.5 embryos were 707 
fixed in 4% PFA and paraffin embedded. At least 3-5 wt embryos per stage were sectioned and 708 
further stained for 5hmC. Briefly, tissue sections were de-waxed in xylene two times for 10 min 709 
each and rehydrated in a graded series of decreasing ethanol concentrations (100% to 50%). To 710 
expose the 5hmC epitope, sections weretreated with 2 N HCl for 30 min and then neutralized 711 
in 100 mM Tris-HCl (pH 8.5) for 10 min. Immunohistochemical detection was performed using 712 
tyramide signal amplification (TSA) according to kit instructions (Perkin Elmer, NEL 700).  713 
We used as primary antibody an anti-5hmC rabbit polyclonal antibody (Active Motif #39769, 714 
1/5000 dilution) andas secondary a donkey anti-rabbit Biotin-SP antibody (Lucron Bioproducts 715 
#711-065-152, 1/300 dilution). Diaminobenzoate chromagen (Dako) was used for signal 716 
visualization. Sections were finally counter-stained with Harris Hematoxylin (Sigma), 717 




  720 
Genomic 5mC and 5hmC quantification. For dot blot assays, 250 ng of DNA were 2-fold 721 
serially diluted in TE buffer, denatured in 0.4 M NaOH/10 mM EDTA at 95°C for 10 min, 722 
neutralized an equal volume of ice-cold 2 M ammonium acetate and kept on ice for 10 min. 723 
Samples were subsequently spotted on a Hybond+ Zeta-Probe nylon membrane (Bio-Rad) 724 
using a 96-well Bio-Dot® apparatus (Bio-Rad). The spotted membrane was rinsed in 2X SSC, 725 
air-dried for 5-10 min and UV crosslinked two times at 120000 µJ/cm2, then blocked in 5% 726 
non-fat milk in TBST for 1hr before incubation overnight at 4°C with anti-5hmC (Active Motif 727 
#39769, 1/10000 dilution) or anti-5mC (Active Motif #39649, 1/5000 dilution) antibodies. 728 
Detection was performed using a HRP-conjugated anti-rabbit (Dako #P0217, 1/5000 dilution) 729 
or anti-mouse (Dako #P0447, 1/5000 dilution) secondary antibody and developed using an 730 
enhanced chemiluminescence reagent (Bio-Rad). On every membrane, a serial dilution of DNA 731 
containing known amounts of 5hmC or 5mC was spotted in parallel as standards. Signal 732 
intensities were measured using ImageJ and calibrated against the linear range of the standard 733 
curves to estimate quantities of 5hmC and 5mC in each sample.  734 
5hmC ELISA was performed using Global 5-hmC Quantification kit (Active Motif). 735 
For mass spectrometry, genomic DNA was extracted using the Promega Wizard kit, treated 736 
with RNase A (NEB), and purified using the DNeasy Blood & Tissue kit (Qiagen). Purified 737 
DNA was hydrolyzed using the DNA degradase plus kit (Zymo). Analysis of DNA hydrolysates 738 
was performed according to Bachman et al.53.  739 
 740 
Derivation of ES cell lines. E3.5 blastocysts were collected from Tet1GT/wt superovulated 741 
females mated with Tet1GT/wt males (> 95% of C57BL/6 background or after 3 out-crosses to 742 
CD1 mice). ESC lines were derived from blastocyst in defined medium containing 2iL as 743 
previously described54. From the B6 incipient congenic embryos, we cultured separately 20 744 
blastocysts and generated a total of 16 independent cell lines: 5 wt, 8 het and 3 Tet1GT/GT (KO). 745 
From CD-1 embryos, we derived 37 independent cell lines from 41 blastocysts: 7 wt, 22 het 746 
and 7 Tet1GT/GT (KO). Western-blot analysis was performed on whole cell lysates using an anti-747 
TET1 antibody (Millipore #09-872, 1/1000 dilution). Karyotyping was performed by mitotic 748 




Cell culture and differentiation. All mouse ESC lines were cultured in standard ESC culture 751 
media as previously described16. When harvesting feeder-cultured cells, cells were feeder-752 
depleted by plating 2 times over 30-45 min on tissue culture plates to remove adherent cells. 753 
Differentiation towards EpiLCs was performed as previously described by bFGF (Peprotech) 754 
without Activin A supplementation35. Trophoblast stem (TS) cells, derived from E6.5 embryos 755 
and generously provided by Dr. J. Rossant, were cultured on mitomycin-inactivated fibroblast 756 
feeders in TS cell media containing RPMI 1640, 20% ES-qualified FBS, 25 ng/ml recombinant 757 
FGF-4 (Peprotech), 1 ng/ml heparin (Sigma-Aldrich), 2 mM L-glutamine, 0.1 mM 758 
βmercaptoethanol, 1 mM sodium pyruvate and 50 units/ml penicillin/streptomycin (Invitrogen). 759 
Afterwards, cells were passaged 1:10 or 1:20 on feeder-free gelatin coated plates and cultured 760 
for 4 days with 70% feeder-conditioned media in the presence or absence of FGF4 and heparin.   761 
 762 
Gene expression analysis. Total RNA was extracted using the RNAeasy Plus Mini kit® 763 
(Qiagen) for cell lines or the RNAeasy micro kit® (Qiagen) for embryos, and converted to 764 
cDNA using SuperScript® III First-Strand Synthesis SuperMix kit (Life Technologies). SYBR 765 
Green-based qPCR (Life Technologies) was performed on either a ViiA™ 7 Real-Time PCR 766 
System or a Step One Plus Real-time PCR System (Applied Biosystems). Primer sequences are 767 
listed in Supplementary Table 8. 768 
 769 
MeDIP-seq and hMeDIP-seq. Genomic DNA was extracted from ESCs after 5 passages in 770 
2iL and upon conversion to EpiLCs as previously described55. Three independent biological 771 
replicates were analyzed. For MeDIP and hMeDIP, anti-5mC (Eurogentec BI-MECY-0100) 772 
and anti-5hmC (Active Motif #39791) were used respectively. Single ends of these libraries 773 
were sequenced on an Illumina HiSeq 2500 with a Version 4 shortread flow cell (Illumina), 774 
yielding ~55 million reads of 50-bp per sample (range 40-90 million). Reads were mapped to 775 
mouse genome build GCRm38 using Bowtie 0.12.8 (-v 2 -m 1 --best -S). Mapping efficiencies 776 
were ~70% for input and hMeDIP, and ~40% for MeDIP, thus matching previous reported 777 
values17.  778 
 779 
5mC and 5hmC DIP enrichment peak calling. Reads were extended in silico to 220 bp, to 780 
match the average insert sizes determined by Bio-analyzer HiSensitivity chips (Illumina). Areas 781 
of enriched MeDIP or hMeDIP signal (i.e. 5(h)mC peaks) were called within SeqMonk 1.0 by 782 
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applying MACS56, using as input store a group of input data (i.e. combining the reads from all 783 
the individual input data sets), and as ChIP store a group of MeDIP or hMeDIP data 784 
(respectively combining reads from all individual MeDIP or hMeDIP data sets). At a P-value 785 
cut-off of 10-5, 241137 MeDIP and 247769 hMeDIP peaks were called from EpiLCs datasets. 786 
Peak areas were filtered for having a relatively even number of reads mapping to the top and 787 
bottom strand (maximally 3-fold difference) to remove potential mapping and DIP artifacts57,58. 788 
Unsupervised hierarchical clustering was performed using the Pearson distance and ward 789 
method. Principle component analysis (PCA) plots and heat maps were generated for the top 790 
1000 differentially (hydroxy-) methylated regions. Differential (hydroxyl-) methylation within 791 
the filtered peaks was analyzed using EdgeR59, and called at false discovery-rates below 5% 792 
(FDR < 0.05) or 10% (FDR<0.1).  793 
 794 
RNA-sequencing. RNA from EpiLCs of 3 independent lines per genotype was isolated using 795 
TRIzol method (Invitrogen). 4μg of total RNA was used for library preparation using KAPA 796 
stranded mRNA Library prep kit for Illumina platform (KAPA Biosystems). Library 797 
concentrations were normalized based on qPCR and equimolar pooled for single-end 798 
sequencing on Illumina HiSeq 2500 with a Version 4 shortread flow cell (Illumina) to yield ~44 799 
million reads (range 41-45 million) of 50-bp read lengths per sample. PCR adapters were 800 
trimmed using FastX (0.013).  801 
In the low input protocol, RNA was purified using the RNeasy micro kit (Qiagen) to 802 
obtain 1-10 ng per pool. First-strand cDNA synthesis and amplification was performed by using 803 
the SMARTer Ultra Low Input RNA amplification kit v3 (Clontech). Single end libraries were 804 
prepared using NEBNext Ultra DNA library prep for Illumina and sequenced on NextSeq 500 805 
yielding ~11 million reads (range 8-13 million) of 75-bp read lengths.  Low quality ends and 806 
adapter sequences were trimmed off from the Illumina reads with FastX 0.0.13 807 
and cutadapt 1.7.1. Using FastX and ShortRead 1.16.3, we filtered subsequently small 808 
reads (length < 35 bp), polyA-reads (>90% of the bases equal A), ambiguous reads (containing 809 
N) and low quality reads (>50% of the bases < Q25).  810 
 811 
Differential expression analysis. Reads from all datasets (EpiLC, Epi and ExE) were aligned 812 
using Tophat v2.0 with default parameter options (--library-type unstranded --min-intron-length 813 
70 --maximum-intron-length 500000) and mapped to mouse genome build GRCm38/mm10. 814 
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Mapping efficiencies of EpiLC datasets >98% and those of in vivo Epi and ExE datasets were 815 
>85%. Samtools1.1 were used to generate aligned BAM files that served as input for read 816 
counting using the summarizeOverlaps count function in R Bioconductor package 817 
GenomicAlignments. Genes with no reads in all samples were filtered out. The features were 818 
counted for single-end reads using the union method in the function, yielding an average of 34 819 
million (78.07% of processed reads), 7.7 million (69.32%) and 7.9 million (69.61%) reads 820 
mapping as unique or primary in EpiLC, Epi and ExE datasets respectively. A read count matrix 821 
of these mapped reads was used as input for differential expression analysis using the DESeq2 822 
package in R. The resulting matrix was used for principle component analysis (PCA) using the 823 
top 1000 differentially expressed genes. The P-values obtained from the DESeq2 analysis were 824 
corrected for multiple testing with Benjamini-Hochberg correction to control the false discovery 825 
rate (FDR). Genes were considered significantly differentially regulated either based on a FDR 826 
value < 0.05 or P < 0.001. Venn diagrams were generated using an online tool 827 
(http://genevenn.sourceforge.net). Differential expression was visualized as heat maps 828 
generated in R using heatmap.2 function. Hierarchical clustering was performed using Pearson 829 
correlation matrix. Reads per kilobase per million (RPKM) values were obtained by aligning 830 
mapped reads to mm10 using Cufflinks (v2.2.1).  831 
 832 
Bisulfite amplicon sequencing analysis. Epiblast and extra-embryonic tissues of E6.25 833 
embryos were pooled by genotype (3-5 per pool) and lysed according to EpiTect Fast Bisulfite 834 
Conversion kit instructions (Qiagen). For Zscan4 locus methylation and hydroxymethylation 835 
analysis, genomic DNA extracted from EpiLCs was converted using the 5hmC TAB-Seq kit 836 
(WiseGene). Bisulfite conversion was performed according to EpiTect Fast Bisulfite 837 
Conversion kit instructions. Nested PCR products were generated using Hifi Taq polymerase 838 
(Invitrogen). Amplicons of 300-450 bp were subsequently purified for library preparation using 839 
the NEBNext Ultra DNA Library prep kit (Illumina) and sequenced on an Illumina MiSeq 600. 840 
Methylation quantification, for sequences with a depth ≥1000, was performed using CLC 841 
genomics workbench (Qiagen) accordingly to previously published pipelines60 with an 842 
additional step to remove duplicate sequences. For TAB-seq, 5mC and 5hmC controls were 843 
added as spiked-in controls in the samples as previously described39. The 5hmC protection by 844 
glucosylation was >80% and the oxidation rate was >95%. For clonal sequencing (GATC 845 
biotech), purified PCR products were subcloned into the pGEM-T Easy vector (Promega). CpG 846 
methylation profiles of sequenced clones were analyzed using QUMA61. Sequences with a 847 
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conversion rate lower than 95%, sequence identity lower than 90% and identical bisulfite 848 
sequences were excluded. Primer sequences are listed in Supplementary Table 8. 849 
 850 
Oxygen consumption rate (OCR) measurement. 4x104 trophoblast stem cells (TSCs) 851 
cultured with and without FGF4 (25 ng/ml) and heparin (1 ng/ml) were seeded onto XFp 852 
Seahorse gelatine-coated well plates 24h before measurement for 90% confluency. Culture 853 
media was replaced with XFp Seahorse base medium supplemented with 2 mM glutamine, 1 854 
mM sodium pyruvate and 10 mM glucose, 1 h prior to the assay and for the duration of the 855 
measurement. Selective inhibitors were injected during the measurements to achieve the final 856 
concentration of oligomycin (2.5 mM), FCCP (300 nM), antimycin (2 mM) following 857 
manufacturer's instruction. Measurements were performed using Seahorse XFp cellular flux 858 
analyzer (Agilent). Measurements were normalized to total protein content per sample. 859 
Maximal respiration rate was calculated by subtracting OCR levels measured at the time of 860 
Oligomycin injection from levels recorded at FCCP injection. .  861 
 862 
Whole genome bisulfite and oxidative bisulfite sequencing. WGBS and oxWGBS was 863 
performed by Novogene Co. Ltd. (China). Briefly, 5 microgram genomic DNA per sample of 864 
2 wt (#15 and #19) and 2 KO (#2 and #12) EpiLCs were fragmented by sonication to 200-300bp 865 
and subjected to bisulfite or oxidative bisulfite treatments using CEGX TrueMethyl Whole 866 
Genome (TMWG) kit (Epigenetix, Cambridge) according to the manufacturer’s instructions. 867 
The resulting single-strand DNA fragments were PCR amplified using KAPA HiFi HotStart 868 
Uracil + ReadyMix (2X). Libraries were sequenced on an Illumina HiSeq X-10 platform to 869 
generate 150-bp paired-end reads. Sequencing of BS libraries generated 582, 525, 546 and 586 870 
million reads for wt19, wt15, KO2 and KO12 samples respectively; oxBS libraries generated 871 
508, 890, 514 and 604 million reads for wt19, wt15 KO2 and KO12 respectively. 872 
 873 
WGBS and oxWGBS analysis. Adapter sequences were trimmed off from the Illumina reads. 874 
Subsequently, reads with ≥10% Ns were removed. In addition, reads with low quality (PHRED 875 
score <= 5, and percentage of the low quality bases >= 50%) were discarded. The remaining 876 
reads were mapped to mouse genome build GRCm38/mm10 using Bismark software (version 877 
0.12.5)62 with default parameters. Reads aligned to the same regions of genome were regarded 878 
as duplicates and counted once. The results of methylation extractor were transformed into 879 
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bigWig format for visualization using IGV browser. A set of 6 control duplexes containing C, 880 
5hmC, 5mC and 5fC bases at known positions, provided in the TMWG kit, was used to estimate 881 
the bisulfite and oxidation conversions rates. In all oxWGBS libraries, oxidation efficiency 882 
based on 5hmC to T conversion was >99%. In all WGBS and oxWGBS libraries, bisulfite 883 
conversion rate based on C to T conversion was >99%.   884 
 885 
Estimation of methylation level. To identify the methylation site, the sum  s+i , j  of methylated 886 
counts were modelled as a binomial (Bin) random variable with methylation rate ri,j 887 
     S+i,j ~ Bin(s+i , j  + s-i , j , ri,j)   888 
To calculate the methylation density, a sliding-window approach was employed. This is 889 
conceptually similar to approaches that have been used for bulk BS-Seq 890 
(http://www.bioconductor.org/packages/2.13/bioc/html/bsseq.html). With window size w = 891 
3,000 bp and step size 600 bp 63, the sum of methylated and unmethylated read counts in 892 
each window were calculated. Methylation level (ML) for each C site shows the fraction of 893 
methylated Cs, and is defined as: 894 
ܯܮ	ሺܿ݋ݎݎ݁ܿݐ݁݀ሻ ൌ ܯܮ െ ݎ1 െ ݎ  895 
The final hmC level is calculated and corrected for the hmC conversion rate using the formula: 896 
hmC_Level ൌ ሺܿݕݐ݋ݏ݅݊݁௥௔௧௜௢ಳೄ െ ܿݕݐ݋ݏ݅݊݁௥௔௧௜௢௡೚ೣಳೄሻ݄݉ܥ_ܿ݋݊ݒ݁ݎݏ݅݋݊_ݎܽݐ݁  897 
Differentially methylated regions (DMRs) were identified using the swDMR software with 898 
default parameters setting the sliding window to 1000bp and step length to 100bp. Fisher test 899 
was implemented to detect the DMRs64. The distribution of DMRs among the genomic features 900 
was generated using ChIPseeker package in R65. 901 
 902 
ChIP-qPCR and ChIP-seq. Cells were trypsinized and fixed in freshly prepared 1% para-903 
formaldehyde at room temperature for 10 min and quenched in 0.125M glycine. Subsequently, 904 
cells were lysed with buffer I (0.25% Triton X-100, 0.5% NP-40, 10% glycerol, 10 mM EDTA, 905 
140 mM NaCl, 10 mM HEPES-KOH, pH 7.5) and washed with buffer II to remove detergents 906 
(200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 10 mM Tris-HCl, pH 8.0). Then nuclei were 907 
lysed in buffer III (100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% Na-Deoxycholate, 0.5% 908 
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N-lauroylsarcosine, 10 mM Tris-HCl, pH 8.0, 0.1% SDS). Nuclear lysates were sheared to 200-909 
500bp using Bioruptor® Plus sonicator (Diagenode, Belgium) set at high power for 20 cycles 910 
(30s ON, 30s OFF). Sheared chromatin was immunoprecipitated using 3µg (for ChIP-qPCR) 911 
or 10µg (for ChIP-seq) of appropriate antibody (Anti-TET1, Millipore #09-872; Anti-6X His 912 
tag antibody, Abcam #ab18184; Anti-V5 tag antibody, Abcam #ab9116) or the same amounts 913 
of control IgG (SantaCruz sc-2027) and incubated overnight with Dyna beads Protein G 914 
(Thermoscientific, 10004D). Immunocomplexes were washed for 5 minutes each sequentially 915 
with the following buffers: 1X low salt buffer (20mM Tris pH 8.1, 150mM NaCl, 2mM EDTA, 916 
1% Triton X-100, 0.1% SDS), 1X high salt buffer (20mM Tris pH 8.1, 500mM NaCl, 2mM 917 
EDTA, 1% Triton X-100, 0.1% SDS), 1X LiCl buffer (10mM Tris pH 8.1, 250mM LiCl, 1mM 918 
EDTA, 1% deoxycholate, 1% NP-40) and 2X TE buffer (+ 50mM NaCl). Chromatin was eluted 919 
with elution buffer (50 mM Tris-HCl, pH 8.0, 10 mM EDTA and 1% SDS) and reversed cross-920 
linked by incubation overnight at 65°C in 5M NaCl buffer. The de-crosslinked DNA samples 921 
were incubated with DNase-free RNase at 37°C for 30 minutes and afterwards with 10 mg/ml 922 
Proteinase K at 55°C for 1-2 hours. DNA was purified using QIAquick PCR Purification kit 923 
(Qiagen, #28106) for qPCR or Zymo ChIP DNA Clean & Concentrator kit (Zymo, #D5201) 924 
for ChIP-seq library preparation. TET1 ChIP-seq was performed on two biological replicates 925 
(two wt and two Tet1-KO EpiLCs). V5-ChIP and His-ChIP were performed on tandem-tagged 926 
N-JMJD8-V5/His expressed in wt EpiLCs. Libraries were prepared using NEBNext Ultra 927 
DNA Library Prep kit for Illumina and sequenced on a HiSeq 2500 to generate 50-bp reads. 928 
FASTQ files were adapter trimmed and mapped using bowtie266. Binding peaks relative to 929 
background (IgG) were called using MACS2 with default parameters56. BED files were further 930 
generated for peak annotation using ChIPSeeker package in R65. ChIP peaks at specific target 931 
genes were visualized using IGV browser. ChIP heat maps were generated using custom R 932 
script. ChIP-PCR primer sequences are listed in Supplementary Table 8. 933 
 934 
Telomere length assay. A telomere PNA kit with fluorescein isothiocyanates (FITC) labeled 935 
probes for flow cytometry (Dako, K5327) was used following the manufacturer’s protocol.  936 
 937 
Cloning JMJD8 over-expression vectors 938 
Jmjd8 coding sequence (CDS) was amplified using Hifi Taq polymerase (Invitrogen) and sub-939 
cloned into the pOZ-FH-N-IRES-CD25 vector, including a 3’end stop codon, between XhoI 940 
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and NotI restriction sites. Subsequently, the FH-JMJD8-IRES-CD25 cassette was digested with 941 
BglII and BamHI and sub-cloned into the pEF1/V5-His vector between KpnI and BamHI sites 942 
to yield pEF1-FH-JMJD8-IRES-CD25. To generate C-terminal tag, Jmjd8 CDS was sub-cloned 943 
in frame with the C-terminal V5-His tag within the pEF1 vector using the KpnI and NotI sites 944 
to generate pEF1-JMJD8-V5-His. We further generated a truncated JMJD8 expression vector 945 
lacking the predicted N-terminal signal peptide, by sub-cloning at the SpeI and NotI sites, to 946 
obtain pEF1-JMJD8-(27-272)-V5-His.  947 
 948 
Luciferase reporter assay. A dual reporter luciferase assay (Promega) was performed in 949 
HEK293T cells in which thymidine kinase promoter-driven Renilla luciferase vector (pRL-TK) 950 
was used as the reporter and the promoter-less firefly luciferase vector (pGL3-Basic) as 951 
normalizing control in 1:5 ratio. To test the activity of JMJD8 and JMJD8, 1 g of the 952 
overexpression construct (pEF1-JMJD8-V5/His or pEF1-JMJD8-V5/His) or control 953 
(pEF1-mock) was co-transfected into the cells using Mirus TransIT-293T transfection reagent 954 
(Mirus Bio). In a second approach, we performed a single reporter assay using SV40 promoter 955 
driven luciferase (pGL3-SV40P) plasmid transfected together with pEF1 vector co-expressing 956 
JMJD8 with a human CD25 surface antigen (pEF1-FH-JMJD8-IRES-CD25) or mock (pEF1-957 
IRES-CD25) in HEK293T cells. 48 hr post transfection, cells were sorted using human CD25 958 
conjugated magnetic beads on a MS column (Myltenyl Bio). Luciferase assay was performed 959 
on the CD25 enriched populations; the readings were further normalized to total protein content 960 
of the cells determined by Bradford assay.  961 
 962 
Immunofluorescence. HEK293T cells were transiently transfected with 1 μg each of V5/His 963 
tagged JMJD8 full-length (1-271 a.a.) or N-terminal truncated (27-271 a.a.; N-JMJD8) 964 
expression constructs. Immunofluorescence was performed on fixed cells using the 6XHis 965 
antibody (Abcam #ab18184) and detected using Alexa fluor-488 secondary antibody (Thermo 966 
Fisher #a-11001). Images were captured using a Leica SP8x confocal microscopy. Nuclear and 967 
cytoplasmic fractions were isolated from cells with standard protocols using a Dounce 968 
homogenizer. Standard Western blotting was performed to detect JMJD8 using the 6xHis 969 
antibody (Abcam #ab18184). Nuclear Lamin A (Santa Cruz #SC-20680) and tubulin (Cell 970 





TET1 and JMJD8 overexpression cell lines. N-JMJD8 CDS was sub-cloned into 974 
pPyCAGIP vector containing puromycin resistance gene and electroporated in mESC.  975 
Puromycin resistant clones were picked and characterized for expression of His/V5 tag. For 976 
TET1 and JMJD8 rescue in KO cell lines, Tet1 wild type, catalytic domain mutant (mHxD) or 977 
N-JMJD8 CDS were subcloned in a piggyBac (PB) transposon vector under the control of a 978 
doxycycline inducible tetO promoter. PB-expression plasmids was co-transfected with vectors 979 
expressing tetracyclin-transactivator (rtTA)–IRES-hygromycin resistance and the transposase 980 
enzyme in molar ratio of ~3:1:1 (PB-TET1 or JMJD8: PB-rtTA: PBase-transposase). 981 
Hygromycin resistant clones were selected and expression of TET1 and JMJD8 CDS was 982 
assayed by western blotting (in presence or absence of 1 µg/ml doxycycline). 983 
 984 
Statistical tests. Two-tailed paired or unpaired t-test were used with 95% confidence interval. 985 
We applied Tukey's HSD (honest significant difference) test for multiple comparison when 986 
ANOVA test was used.  987 
 988 
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